Abstract: Various approaches for the deployment and coordination of network operation processing, compute processing, and communications for 5G networks, including with the use of fingerprint-based vRAN cell integrity monitoring, are discussed. In an example, analyzing a state of a 5G network includes: obtaining initial fingerprint reference data of a network state between a virtualized radio access network (vRAN) node and at least one fingerprint reference unit (FRU) device wirelessly connected to the vRAN node; comparing the initial fingerprint reference data to subsequent fingerprint data of the network state between the vRAN node (e.g., operating as vRAN gNB, or as an IAB Donor or IAB Node) and the at least one FRU device to detect a changed network condition; and performing an action at the vRAN node to modify or disable a component of the 5G network, in response to detection of the changed network condition.

Abstract: GnRH receptor antagonists are disclosed which have utility in the treatment of a variety of sex-hormone related conditions in both men and women. The compounds of this invention have the structure: wherein A, R1, R2, R3a, R3b, R4, R5, R6, R7 and n are as defined herein, including stereoisomers, prodrugs and pharmaceutically acceptable salts thereof. Also disclosed are compositions containing a compound of this invention in combination with a pharmaceutically acceptable carrier, as well as methods relating to the use thereof for antagonizing gonadotropin-releasing hormone in a subject in need thereof.

Abstract: GnRH receptor antagonists are disclosed which have utility in the treatment of a variety of sex-hormone related conditions in both men and women.

Abstract: GnRH receptor antagonists are disclosed which have utility in the treatment of a variety of sex-hormone related conditions in both men and women.

Abstract: An embedded antenna subsystem wherein a board supports electronic components and a pair of radiating elements are mounted along the periphery of the board. It is emphasized that this abstract is provided to comply with the rules requiring an abstract which will allow a searcher or other reader to quickly ascertain the subject matter of the technical disclosure. It is submitted with the understanding that it will not be used to interpret or limit the scope or the meaning of the claims.

Abstract: GnRH receptor antagonists are disclosed which have utility in the treatment of a variety of sex-hormone related conditions in both men and women.

Abstract: GnRH receptor antagonists are disclosed which have utility in the treatment of a variety of sex-hormone related conditions in both men and women. The compounds of this invention have the structure: wherein Ar, A, B, Q, R1, R2, R3a, R3b, R6, R7 and m are as defined herein, including stereoisomers, prodrugs and pharmaceutical acceptable salts thereof. Also disclosed are compositions containing a compound of this invention in combination with a pharmaceutically acceptable carrier, as well as methods relating to the use thereof for antagonizing gonadotropin-releasing hormone in a subject in need thereof.

Abstract: GnRH receptor antagonists are disclosed which have utility in the treatment of a variety of sex-hormone related conditions in both men and women.

Abstract: A two- or a one-step process and composition which coats metal workpiece surfaces (aluminum, copper, steel, stainless steel, etc.) with a thin lubricant film capable of allowing the metal to be deformed at room temperature. The lubricant consists essentially of polymers, dispersants, high molecular weight waxes and insoluble metallic stearates. With some ferrous surfaces, a separate coating layer is simultaneously formed (in the one-step process) or pre-formed (in the two-step process) at the metal interface, acting as a base for the lubricant. The process, after pickling in a mineral acid to remove scale and oxides, comprises the step(s) of immersing the workpiece either once or twice. The workpiece is then dried in a heated, forced air dryer.

Abstract: GnRH receptor antagonists are disclosed which have utility in the treatment of a variety of sex-hormone related conditions in both men and women. The compounds of this invention have the structure: including stereoisomers, prodrugs and pharmaceutically acceptable salts thereof, wherein Ar, B, R1, R2, R3a, R3b, R4, R5, R6 and m are as defined herein.

Abstract: A composition for lubricating a metal workpiece prior to cold forming consists essentially of: an aqueous alkaline stearate compound present in an amount sufficient to impart metal lubrication between about 180.degree. F. and about 320.degree. F.; an aqueous alkaline palmitate compound present in an amount sufficient to impart metal lubrication below about 160.degree. F.; an aqueous metallic stearate compound present in an amount sufficient to impart metal lubrication between about 320.degree. F. and 440.degree. F.

Abstract: A composition for lubricating a metal workpiece prior to cold forming consists essentially of: an aqueous alkaline stearate compound present in an amount sufficient to impart metal lubrication between about 180.degree. F. and about 320.degree. F.; an aqueous alkaline palmitate compound present in an amount sufficient to impart metal lubrication below about 160.degree. F.; an aqueous metallic stearate compound present in an amount sufficient to impart metal lubrication between about 320.degree. F. and 440.degree. F.

Abstract: A composition for lubricating a metal workpiece prior to cold forming consists essentially of: an aqueous alkaline stearate compound present in an amount sufficient to impart metal lubrication between about 180.degree. F. and about 320.degree. F.; an aqueous alkaline palmitate compound present in an amount sufficient to impart metal lubrication below about 160.degree. F.; an aqueous metallic stearate compound present in an amount sufficient to impart metal lubrication between about 320.degree. F. and 440.degree. F.